1. Report to the Council by the Working Party on Leukaemia in Childhood. Improvement in treatment for children with acute lymphoblastic leukaemia;The Medical Research Council UKALL Trials; Lancet,1972
2. Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization;Lilleyman, J.S.; Lennard, L.; Rees, C.A.; Morgan, G.; Maddocks, J.L.;Brj Cancer,1984
3. The Medical Research Council's Working Party on Leukaemia in Childhood. The treatment of acute lymphoblastic leukaemia (ALL) in childhood, UKALL III. The effects of added cytosine arabinoside and/or asparaginase, and a comparison ofcontinuous or discontinuous mercaptopurine in regimens for standard risk ALL;Med Pediatr Oncol,1982
4. Report to the Council by the Working Party on Leukaemia in Childhood. Medical Research Council Leukaemia TrialUKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukaemia;J Clin Oncol,1986
5. Design and analysis of randomized clinical trials requiring prolonged observation of each patient;Peto, R.; Pike, M.C.; Armitage, P.;II. Analysis and examples. Br J Cancer,1977